Insilico Medicine– tag –
-
Insilico Medicine’s AI Platform Identifies Novel Fibrosis Target, Accelerating Preclinical Drug Development
BioRender News USA Overview Insilico Medicine announced its AI-driven drug discovery platform successfully identified a novel therapeutic target for specific fibrotic diseases, validated by in vitro experiments. This high-precision predi... -
Insilico Medicine and Saudi Aramco Unveil ‘Sanity Pipeline’ for AI-Driven MOF Discovery
Insilico Medicine (Press Release), ChemRxiv (Preprint reference) Hong Kong Overview Insilico Medicine and Saudi Aramco have introduced the "Sanity Pipeline," an innovative AI-driven tool designed to tackle structural validity challenges ... -
Eli Lilly Seals Landmark $2.75 Billion AI Drug Discovery Alliance with Insilico Medicine
IntuitionLabs, TipRanks, Tech Funding News USA Overview Pharmaceutical giant Eli Lilly has forged a strategic drug discovery and development collaboration with AI biotech pioneer Insilico Medicine, valued at up to $2.75 billion. The deal...
